Skip to main content
Interpace looks to obtain $10.5M in public offering

Interpace Diagnostics will launch a public offering of nearly 6.3 million shares of its common stock in hopes of obtaining approximately $10.5 million in net proceeds, according to a filing with the SEC. The company intends to use the proceeds as working capital, as well as for general corporate functions, trade, payables and other obligations.

Full Story: